| scholarly article | Q13442814 |
| P2093 | author name string | Zhihua Yin | |
| Zhizhong Ye | |||
| Jinxian Huang | |||
| Guoxiang Song | |||
| Zhongchao Fu | |||
| P2860 | cites work | The Wnt signaling pathway in development and disease | Q27861019 |
| Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis | Q28296891 | ||
| A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation | Q29618700 | ||
| Increased serum alkaline phosphatase activity in ankylosing spondylitis | Q33554759 | ||
| Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis | Q33565447 | ||
| Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis | Q33578146 | ||
| Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
| Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis | Q34425497 | ||
| Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study | Q34457833 | ||
| Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system | Q35554631 | ||
| Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors | Q36907665 | ||
| Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis | Q37040977 | ||
| Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years | Q37350944 | ||
| Clinical utility of serum sclerostin measurements | Q37605570 | ||
| The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? | Q37857468 | ||
| Wnt signaling in ankylosing spondylitis | Q38211262 | ||
| Etanercept in the longterm treatment of patients with ankylosing spondylitis | Q42619535 | ||
| Serum alkaline phosphatase in ankylosing spondylitis | Q42706417 | ||
| Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis | Q43927224 | ||
| Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. | Q44076079 | ||
| Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity. | Q44624124 | ||
| Sclerostin and Dkk-1 in patients with ankylosing spondylitis | Q44776603 | ||
| The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis | Q44934503 | ||
| Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis | Q45183754 | ||
| Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis | Q48400472 | ||
| Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept | Q48533541 | ||
| Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. | Q51756072 | ||
| Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis. | Q53223028 | ||
| Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. | Q53411277 | ||
| Biomarkers of Bone Metabolism in Ankylosing Spondylitis in Relation to Osteoproliferation and Osteoporosis | Q57623454 | ||
| Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, | Q61540553 | ||
| Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis | Q61895121 | ||
| Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures | Q73101160 | ||
| Biochemical bone turnover markers in patients with ankylosing spondylitis | Q73737287 | ||
| Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis | Q77766900 | ||
| Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity | Q79235364 | ||
| Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
| Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? | Q79721083 | ||
| Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis | Q79973633 | ||
| Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis | Q82097915 | ||
| Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis | Q82357588 | ||
| Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores | Q82414520 | ||
| ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis | Q82854967 | ||
| High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis | Q83079558 | ||
| Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis | Q84819852 | ||
| Serum functional dickkopf-1 levels are inversely correlated with radiographic severity of ankylosing spondylitis | Q85703286 | ||
| Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation | Q85884911 | ||
| Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis | Q88072317 | ||
| P433 | issue | 3 | |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| P304 | page(s) | 221-228 | |
| P577 | publication date | 2016-04-15 | |
| P1476 | title | Alteration of Bone Turnover Markers in Canonical Wingless Pathway in Patients With Ankylosing Spondylitis | |
| P478 | volume | 31 |
Search more.